Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $2.93 +0.09 (+3.17%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$3.08 +0.15 (+5.12%) As of 04/4/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Stock Price Performance 5 Day Performance-9.29%1 Month Performance-29.06%3 Month Performance-35.18%6 Month Performance-46.04%Year-To-Date Performance-28.88%1 Year Performance-58.14% Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TELO Stock Chart for Saturday, April, 5, 2025 TELO Chart by TradingViewRemove Ads Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$2.84$2.93+3.17%$3.08$2.61178,838 shs$87.21 million04/03/2025$3.13$2.84-9.27%$3.10$2.83190,856 shs$84.53 million04/02/2025$2.74$3.13+14.23%$3.40$2.81478,137 shs$93.16 million04/01/2025$3.23$2.74-15.17%$3.49$2.73275,642 shs$81.55 million03/31/2025$3.95$3.23-18.23%$4.01$3.23283,348 shs$96.13 million03/28/2025$4.02$3.95-1.74%$4.06$3.88115,429 shs$117.56 million03/27/2025$4.12$4.02-2.43%$4.19$3.96245,823 shs$119.65 million03/26/2025$4.34$4.12-5.07%$4.55$4.10111,552 shs$122.62 million03/25/2025$4.53$4.34-4.19%$4.54$4.26115,430 shs$129.17 million03/24/2025$4.56$4.53-0.66%$4.80$4.35225,131 shs$134.83 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$4.08$4.56+11.76%$4.63$3.90670,838 shs$135.72 million03/20/2025$4.35$4.08-6.21%$4.54$4.0680,942 shs$121.43 million03/19/2025$4.12$4.35+5.58%$4.44$4.09109,930 shs$129.47 million03/18/2025$4.17$4.12-1.20%$4.57$3.91150,794 shs$122.62 million03/17/2025$4.58$4.17-8.95%$4.83$4.14118,068 shs$124.11 million03/14/2025$5.03$4.58-8.95%$5.23$4.50307,965 shs$136.32 million03/13/2025$4.94$5.03+1.82%$5.40$4.76198,378 shs$149.71 million03/12/2025$4.54$4.94+8.81%$4.98$4.36103,510 shs$147.03 million03/11/2025$4.23$4.54+7.33%$4.60$4.13122,914 shs$135.12 million03/10/2025$4.35$4.23-2.76%$4.43$4.03106,855 shs$125.90 million03/07/2025$4.14$4.35+5.07%$4.48$4.05130,090 shs$129.47 million03/06/2025$4.13$4.14+0.24%$4.17$4.0346,872 shs$123.22 million03/05/2025$4.05$4.13+1.98%$4.45$4.01147,365 shs$122.92 million03/04/2025$4.11$4.05-1.46%$4.28$3.80403,878 shs$120.54 million Related Companies Oruka Therapeutics Stock Price Chart Revance Therapeutics Stock Price Chart Kamada Stock Price Chart Sana Biotechnology Stock Price Chart SNDL Stock Price Chart Upstream Bio Stock Price Chart Rapport Therapeutics Stock Price Chart Stoke Therapeutics Stock Price Chart REGENXBIO Stock Price Chart Mereo BioPharma Group Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELO Stock Free TELO Stock Alerts